Posizioni attive di Lloyd Sanders
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Epic Sciences, Inc.
 Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 25/03/2019 | - |
| Amministratore Delegato | 25/03/2019 | - | |
| Presidente | 25/03/2019 | - |
Storia della carriera di Lloyd Sanders
Precedenti posizioni note di Lloyd Sanders
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Mylan Specialty LP
 Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Direttore operativo | 06/05/2011 | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Chief Operating Officer | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Mylan Specialty LP
Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Health Technology |
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Lloyd Sanders
- Esperienza
